CapsoVision, Inc. vs Sight Sciences, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Sight Sciences, Inc. is the larger company by market value: $448 M against $372 M for CapsoVision, Inc., 1.2 times as much (market caps of Oct 30, 2026 for CapsoVision, Inc. and Aug 1, 2026 for Sight Sciences, Inc.). Sight Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Sight Sciences, Inc. had more revenue: $77 M against $14 M for CapsoVision, Inc., both in the year to December 2025.
- Both made a net loss: $25 M for CapsoVision, Inc. and $38 M for Sight Sciences, Inc.
- Sight Sciences, Inc. keeps more of each dollar of sales: a net margin of -49.7% against -186.9% for CapsoVision, Inc.
- Sight Sciences, Inc. employs more people: 186 against 99 at CapsoVision, Inc. Each employee brings in about $136,869 of revenue at CapsoVision, Inc. and $415,914 at Sight Sciences, Inc.
- CapsoVision, Inc.'s revenue grew faster in its latest fiscal year: +15.2% against -3.1% for Sight Sciences, Inc.
- Their Altman Z-scores put CapsoVision, Inc. in the safe zone and Sight Sciences, Inc. in the distress zone.
Market value, the same start = 100
From Aug 2026: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | CapsoVision, Inc. CV · #13,827 in the world | Sight Sciences, Inc. SGHT · #13,040 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Founded | — | 2010 |
| Size | ||
| Market cap | $372 M | $448 M |
| Revenue | $14 M | $77 M |
| Net income | $-25 M▲ best | $-38 M |
| Employees | 99 | 186 |
| Valuation | ||
| Price to sales | 26.8× | 5.1× |
| Price to book | 28.1× | 7.0× |
| Free cash flow yield | -6.2%▲ best | -6.7% |
| Profitability | ||
| Gross margin | 52.9% | 86.2%▲ best |
| Operating margin | -188.3% | -48.0%▲ best |
| Net margin | -186.9% | -49.7%▲ best |
| Return on equity | — | -50.8% |
| Growth | ||
| Revenue growth | 15.2%▲ best | -3.1% |
| Revenue growth, 3 years a year | — | 2.7% |
| Financial strength | ||
| Debt to equity | — | 0.7× |
| Interest cover | — | -7.2× |
| Cash | ||
| Free cash flow margin | -169.4% | -38.7%▲ best |
| Strength scores | ||
| Piotroski F-score | — | 5 of 9 |
| Altman Z-score zone | safe | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026; ratios FY2025 |
Questions and answers#
Which is bigger, CapsoVision, Inc. or Sight Sciences, Inc.?
Sight Sciences, Inc. is the larger company by market value: $448 M against $372 M for CapsoVision, Inc., 1.2 times as much (market caps of Oct 30, 2026 for CapsoVision, Inc. and Aug 1, 2026 for Sight Sciences, Inc.). Sight Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, CapsoVision, Inc. or Sight Sciences, Inc.?
Sight Sciences, Inc. had more revenue: $77 M against $14 M for CapsoVision, Inc., both in the year to December 2025. Both made a net loss: $25 M for CapsoVision, Inc. and $38 M for Sight Sciences, Inc.
Which is more profitable, CapsoVision, Inc. or Sight Sciences, Inc.?
Sight Sciences, Inc. keeps more of each dollar of sales: a net margin of -49.7% against -186.9% for CapsoVision, Inc.
Which has more employees, CapsoVision, Inc. or Sight Sciences, Inc.?
Sight Sciences, Inc. employs more people: 186 against 99 at CapsoVision, Inc. Each employee brings in about $136,869 of revenue at CapsoVision, Inc. and $415,914 at Sight Sciences, Inc.
Which is growing faster, CapsoVision, Inc. or Sight Sciences, Inc.?
CapsoVision, Inc.'s revenue grew faster in its latest fiscal year: +15.2% against -3.1% for Sight Sciences, Inc.
Which is financially stronger, CapsoVision, Inc. or Sight Sciences, Inc.?
Their Altman Z-scores put CapsoVision, Inc. in the safe zone and Sight Sciences, Inc. in the distress zone.